Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials-Reference-Cited by-同舟云学术

Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials

Published:2002-11 Issue:5 Volume:168 Page:1964-1970
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

SYLVESTER RICHARD J.¹,van der MEIJDEN ADRIAN P.M.¹,LAMM DONALD L.¹

Affiliation:

1. From the European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium, Jeroen Bosch Hospital, ’ s-Hertogenbosch, The Netherlands, and the Mayo Clinic, Scottsdale, Arizona

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference34 articles.

1. Adjuvant intravesicular pharmacotherapy for superficial bladder cancer;Lum;J Natl Cancer Inst,1991

2. A combined analysis of European Organization for research and treatment of cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer;Pawinski;J Urol,1996

3. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder;Lamm;J Urol,1995

4. A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer;Shelley;BJU Int,2001

5. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997

Cited by 1048 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2024-09

2. Neue Therapieansätze beim nicht-muskelinvasiven Urothelkarzinom der Harnblase – Ist der Organerhalt auch nach BCG (Bacillus Calmette-Guérin) möglich?;Die Urologie;2024-08-23

3. Signal mining and gender differences analysis of adverse events in NMIBC treatment with gemcitabine and BCG bladder instillation based on the FAERS database;Expert Opinion on Drug Safety;2024-08-08

4. Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial;European Urology;2024-08

5. Comparison of PDD-TURBT alone versus white light TURBT plus intravesical BCG therapy: A propensity-score matching study;Photodiagnosis and Photodynamic Therapy;2024-08